INSIGHTS ON PHARMACEUTICAL PACKAGING

• Design Verification Testing Of Combination Products

  Developing a combination product and seeking a list of tests to complete design verification testing? Review the details for planning, design inputs, design outputs, and design verification.

• Why Compounding Pharma Manufacturers Should Evaluate BFS Systems

  Discover how BFS technology offers compounding pharmacies and 503B facilities enhanced sterility, reduced errors, cost savings, and superior product integrity for aseptic pharmaceutical manufacturing.

• 6 Strategic Pillars For Selecting A Drug Packaging Partner

  Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

• The Rising Need For Flexibility In Blister Packaging For CDMOs And Drug Manufacturers

  In the pharmaceutical industry, processes are subject to continuous change due to evolving requirements and regulations. Consequently, pharmaceutical companies and contract packagers often require adaptable packaging solutions, such as blister machines, to meet these dynamic needs.

• Delivering On GLP-1 Demand: Combining Device And Supply Strategy

  5/7/2024

  Meeting the demand for GLP-1 treatments requires robust and efficient delivery systems. Review how innovative solutions offer customization, streamlined manufacturing, and formulation compatibility.

• A Robust Extractables Data Package Helps Drive Patient Safety

  10/1/2024

  Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product.

• Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

  5/9/2024

  Explore the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

• Supporting GLP-1 And Peptides With Integrated Solutions

  9/30/2025

  Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.

• Meeting Annex 1: A Proactive Approach To Regulatory Compliance

  3/4/2025

  It was imperative for a large European CMO producing multiple biologics to select the right product quality and value for each customer to comply with the August 2023 EU GMP Annex 1 revision.